ZTS

Zoetis

Halal Rating :
Uncomfortable
Last Price $164.64 Last updated:
Market Cap $79.07b
7D Change -7.6%
1 Year Change -15.42%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 31, 2024

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.39b $1.53b - $57.0m 0.00% 3.73%
June 30, 2024 $2.36b $1.56b - $59.0m 0.00% 3.79%
March 31, 2024 $2.19b $1.45b - $58.0m 0.00% 4.00%

Company Impact

Help us evaluate Zoetis's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates